冠轈控股(1872.HK)再度暴跌较上一交易日最高价跌去90%
格隆汇8月19日丨继上周五盘中创出上市新高价5港元,但在尾盘跳水暴跌78.89%后,冠轈控股(1872.HK)今日再现暴跌走势,现报0.39港元,暴跌60.61%,暂成交9981万港元,最新总市值3.46亿港元。盘中一度创出上市新低价0.325港元,相比于上个交易日盘中创出的新高价5港元跌去93.5%。暴跌前该股曾连续5日大涨,累涨121%。冠轈控股(1872.HK)于今年2月28日以0.43港元上市,目前股价处于IPO发行价下方。值得注意的是,8月28日即将有3.35亿股限售股(港股首发)迎来解禁。此外,公司曾在8月6日发盈警,预计中期净利润变动幅度为-60%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.